Biogen Newsroom

Truist Financial Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $220

Moomoo News21:31 ET

Truist Financial Sticks to Their Buy Rating for Biogen (BIIB)

TipRanks20:19 ET

RBC Capital Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $231

Moomoo NewsJan 7 08:37 ET

RBC Cuts Price Target on Biogen to $231 From $260, Keeps Outperform Rating

MT NewswiresJan 7 07:03 ET

Biogen Analyst Ratings

BenzingaJan 2 11:18 ET

Piper Sandler Downgrades Biogen to Neutral, Lowers Price Target to $138

BenzingaJan 2 11:18 ET

Leerink Partners Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $290

Moomoo NewsDec 20, 2024 13:43 ET

BMO Capital Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $164

Moomoo NewsDec 20, 2024 13:43 ET

Biogen's Challenges and Cautious Outlook: Hold Rating Amid Revenue Growth Struggles and Neurology Market Hurdles

TipRanksDec 20, 2024 13:13 ET

Biogen Cut to Market Perform From Outperform by BMO Capital

Dow JonesDec 20, 2024 05:16 ET

Biogen Analyst Ratings

BenzingaDec 20, 2024 05:07 ET

BMO Capital Downgrades Biogen to Market Perform, Lowers Price Target to $164

BenzingaDec 20, 2024 05:06 ET

Stifel Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $175

Moomoo NewsDec 16, 2024 06:32 ET

Biogen Downgraded to Hold From Buy at Stifel

TipRanksDec 16, 2024 06:23 ET

Stifel Downgrades Biogen to Hold From Buy, Adjusts Price Target to $175 From $275

MT NewswiresDec 16, 2024 05:43 ET

Biogen Analyst Ratings

BenzingaDec 10, 2024 07:55 ET

B of A Securities Reinstates Neutral on Biogen, Announces $178 Price Target

BenzingaDec 10, 2024 07:39 ET

Biogen Analyst Ratings

BenzingaDec 9, 2024 06:42 ET

Jefferies Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $180

Moomoo NewsDec 9, 2024 06:31 ET

Biogen's Modest Growth Prospects and Revenue Challenges Highlighted in Hold Rating

TipRanksDec 9, 2024 05:40 ET